FibroBiologics, Inc. Common Stock
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $8,889,000.
Profit Margin
| 2020 | 0 | -1.16M | |
|---|---|---|---|
| 2023 | 0 | -16.48M |
FBLG Income Statement (2020 – 2023)
| 2023 | 2020 | |
|---|---|---|
Revenue | ||
Revenue | 0 | 0 |
Cost of revenue | 437K | 0 |
Gross profit | -437K | 0 |
Operating exp. | ||
Research and development | 2.36M | 669K |
Selling and marketing | 685K | 0 |
Total operating expenses | 8.88M | 1.16M |
Operating income | -8.88M | -1.16M |
Other income (expenses), net | -7.59M | 0 |
Income before tax | -16.48M | -1.16M |
Income tax expense | 0 | 0 |
Net income | -16.48M | -1.16M |
Earnings per share | ||
Basic EPS | -0.59 | -0.13 |
Diluted EPS | -0.68 | -0.13 |